This inventor holds 1 USPTO granted patent. Top assignee: Ferring Laboratories, Inc.. Active years: 1988.
Company Filing History:
Years Active: 1988
Title: The Innovations of Daniel M Linkie
Introduction
Daniel M Linkie is an accomplished inventor based in Suffern, NY (US). He has made significant contributions to the field of veterinary medicine through his innovative approaches to growth hormone administration. His work focuses on improving therapeutic treatments for living animals, particularly in the context of growth hormone therapies.
Latest Patents
Daniel M Linkie holds a patent for an "Apparatus and methodology for pulsed administration of growth promoting." This patent describes a method and apparatus for therapeutically effective treatment of a living animal. It involves administering a dynamic dosage of growth hormone releasing factor or its analogs, or administering growth hormone or its analogs in a chronic course of treatment using a subdesensitizing regimen. Additionally, the patent outlines a method for diagnosing living animals with an anterior pituitary that is unresponsive to growth hormone releasing factor or its analogs. It also includes a method for determining the optimum dynamic dosage of GRF and GH for a given living animal, particularly humans.
Career Highlights
Daniel M Linkie is associated with Ferring Laboratories, Inc., where he continues to develop and refine his innovative methodologies. His work has the potential to significantly impact the field of veterinary medicine and improve the quality of life for many animals.
Collaborations
One of his notable collaborators is Michael Oliver Thorner, with whom he has worked closely to advance their shared goals in the field of growth hormone research.
Conclusion
Daniel M Linkie's contributions to the field of veterinary medicine through his innovative patent demonstrate his commitment to improving animal health. His work continues to pave the way for advancements in growth hormone therapies.